Updated analysis of brentuximab vedotin, nivolumab, doxorubicin, and dacarbazine for nonbulky, early-stage classical Hodgkin lymphoma Meeting Abstract
| Authors: | Abramson, J. S.; Straus, D. J.; Bartlett, N. L.; Burke, J. M.; Lynch, R. C.; Domenech, E. D.; Hess, B.; Schuster, S.; Linhares, Y.; Ramchandren, R.; Gandhi, M.; Shah, H. R.; Jurczak, W.; Re, A.; Hahn, U.; Prince, H. M.; Guo, W.; Davis, G.; Ho, L.; Yasenchak, C.; Lee, H. J. |
| Abstract Title: | Updated analysis of brentuximab vedotin, nivolumab, doxorubicin, and dacarbazine for nonbulky, early-stage classical Hodgkin lymphoma |
| Meeting Title: | 66th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 144 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Dec 7-10 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2024-11-05 |
| Start Page: | 461 |
| End Page: | 462 |
| Language: | English |
| ACCESSION: | WOS:001415654100010 |
| DOI: | 10.1182/blood-2024-200992 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
